The Brazilian COVID-19 vaccination campaign: A modelling analysis of socio-demographic factors on uptake
Li, S. L.; Prete, C. A.; Zarebski, A. E.; de Souza Santos, A. A.; Sabino, E. C.; Nascimento, V. H.; Wu, C.-H.; Messina, J. P.
Show abstract
The COVID-19 pandemic has caused over half a million deaths in Brazil, and public healthcare nearly collapsed. Vaccination differs between states and demographics. Dose shortages delayed access. In this cross-sectional study, data were retrieved from the Brazilian Ministry of Health databases published since 17 January 2021, respectively. We developed a campaign optimality index to characterise inequality in vaccination access caused by age due to premature vaccination towards younger populations before older and vulnerable populations were fully vaccinated. We assessed geographical inequalities in full vaccination coverage and dose by age, sex, race, and socioeconomic status. Generalised linear regression was used to investigate the risk of death and hospitalisation by age group, socioeconomic status, and vaccination coverage. Vaccination coverage is higher in the wealthier South and Southeast. Men, people of colour, and low-income groups were more likely to be only partially vaccinated due to missing or delaying a second dose. Vaccination started prematurely for age groups under 50 years and may have hindered uptake of older age groups. Vaccination coverage was associated with a lower risk of death, especially in older age groups (OR: 10.5-34.8, 95% CI: (10.2, 35.9)). Risk of hospitalisation was greater in areas with higher vaccination rates due to higher access to care and reporting. Vaccination inequality persists between states, age and demographic groups despite increasing uptake. The association between hospitalisation rates and vaccination is attributed to preferential delivery to areas of greater transmission and access to healthcare.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- COVID-19 vaccine uptake and effectiveness by time since vaccination in the Western Cape province, South Africa: An observational cohort study during 2020-2022 95%
- Effectiveness of ChAdOx1 nCoV-19 Corona Virus Vaccine (Covishield™) in preventing SARS-CoV2 infection, Chennai, Tamil Nadu, India, 2021 94%
- Determinants of COVID-19 vaccine uptake in the Netherlands: a nationwide registry-based study 94%
Similar papers in this journal
- Impact of CoronaVac on Covid-19 outcomes of elderly adults in a large and socially unequal Brazilian city: A target trial emulation study 96%
- Averted mortality by COVID-19 vaccination in Belgium between 2021 and 2023 95%
- Number of COVID-19 hospitalisations averted by vaccination: Estimates for the Netherlands, January 6, 2021 through August 30, 2022 95%
Similar papers in this journal
- Time-Varying Effectiveness of Three Covid-19 Vaccines in Puerto Rico 97%
- Effectiveness of CoronaVac in the setting of high SARS-CoV-2 P.1 variant transmission in Brazil: A test-negative case-control study 95%
- Protection of homologous and heterologous boosters after primary schemes of rAd26-rAd5, ChAdOx1 nCoV-19 and BBIBP-CorV during the Omicron outbreak in adults of 50 years and older in Argentina: a test-negative case-control study 93%
Similar papers in this journal
- Vaccine Rollout Strategies: The Case for Vaccinating Essential Workers Early 92%
- Rural prioritization may increase the impact of COVID-19 vaccines in Sub-Saharan Africa due to ongoing internal migration: A modeling study 92%
- Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): a single blind, randomized, non-inferiority trial 92%
Similar papers in this journal
- Comparison of COVID-19 vaccine prioritization strategies in the United States 93%
- COVID-19 vaccines that reduce symptoms but do not block infection need higher coverage and faster rollout to achieve population impact 93%
- Durability of SARS-CoV-2 IgG Antibodies: Insights from a Longitudinal Study, Puerto Rico 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.